Scientists probe immune cells in pneumonia to unlock ARDS secrets
NCT ID NCT03379207
First seen Jan 08, 2026 · Last updated Jun 23, 2026 · Updated 20 times
Summary
This study looked at how certain immune cells, called non-conventional T cells, behave in patients with severe pneumonia and acute respiratory distress syndrome (ARDS). Researchers collected blood and airway samples from 258 intensive care unit patients to track these cells over time. The goal was to better understand the immune response that can lead to worsening illness, which may help improve future treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University Hospitakl of TOURS Département of Pneumonia
Tours, 37044, France
-
University Hospital -Bretonneau - Intensive Care
Tours, 37044, France
-
University Hospital of Tours; INSERM CIC 1415
Tours, 37044, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better understand why some pneumonia cases turn severe, potentially pointing to new ways to predict or treat complications like ARDS.
What could go wrong
This is an observational study that was terminated early, so results may be limited. It does not test a treatment, so direct patient benefits are not guaranteed.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.